Literature DB >> 16004849

Which treatment for patent foramen ovale in cryptogenic stroke?

Isabelle Mahé1, Charles Caulin, Jean-François Bergmann.   

Abstract

The management of a patient with a cryptogenic stroke and a patent foramen ovale (PFO) depends on the existence of identifiable causes of stroke, on the PFO characteristics, on the characteristics of the patient, on the contraindications to antithrombotic therapy, and on the preference of the patient. There is no consensus on the management of a patient with a cryptogenic stroke and a PFO, but the algorithm presented in this article seems reasonable to these authors.

Entities:  

Year:  2005        PMID: 16004849     DOI: 10.1007/s11936-005-0046-7

Source DB:  PubMed          Journal:  Curr Treat Options Cardiovasc Med        ISSN: 1092-8464


  16 in total

1.  Interobserver and intraobserver variability in detection of patent foramen ovale and atrial septal aneurysm with transesophageal echocardiography.

Authors:  Laure Cabanes; Joël Coste; Geneviève Derumeaux; Xavier Jeanrenaud; Catherine Lamy; Mathieu Zuber; Jean-Louis Mas
Journal:  J Am Soc Echocardiogr       Date:  2002-05       Impact factor: 5.251

2.  Stroke recurrence in patients with patent foramen ovale: the Lausanne Study. Lausanne Stroke with Paradoxal Embolism Study Group.

Authors:  J Bogousslavsky; S Garazi; X Jeanrenaud; N Aebischer; G Van Melle
Journal:  Neurology       Date:  1996-05       Impact factor: 9.910

3.  Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts.

Authors:  P T Hagen; D G Scholz; W D Edwards
Journal:  Mayo Clin Proc       Date:  1984-01       Impact factor: 7.616

4.  Cost implications of closure of atrial septal defect.

Authors:  Sherri S Baker; Martin P O'Laughlin; James G Jollis; J Kevin Harrison; Stephen P Sanders; Jennifer S Li
Journal:  Catheter Cardiovasc Interv       Date:  2002-01       Impact factor: 2.692

5.  Surgical patent foramen ovale closure for prevention of paradoxical embolism-related cerebrovascular ischemic events.

Authors:  J A Dearani; B S Ugurlu; G K Danielson; R C Daly; C G McGregor; C J Mullany; F J Puga; T A Orszulak; B J Anderson; R D Brown; H V Schaff
Journal:  Circulation       Date:  1999-11-09       Impact factor: 29.690

6.  Surgical closure of patent foramen ovale in cryptogenic stroke patients.

Authors:  S Homma; M R Di Tullio; R L Sacco; R R Sciacca; C Smith; J P Mohr
Journal:  Stroke       Date:  1997-12       Impact factor: 7.914

7.  Secondary prevention of cerebral ischemia in patent foramen ovale: systematic review and meta-analysis.

Authors:  M A Orgera; P G O'Malley; A J Taylor
Journal:  South Med J       Date:  2001-07       Impact factor: 0.954

8.  Percutaneous closure of patent foramen ovale in patients with paradoxical embolism: long-term risk of recurrent thromboembolic events.

Authors:  S Windecker; A Wahl; T Chatterjee; A Garachemani; F R Eberli; C Seiler; B Meier
Journal:  Circulation       Date:  2000-02-29       Impact factor: 29.690

9.  Comparison of medical treatment with percutaneous closure of patent foramen ovale in patients with cryptogenic stroke.

Authors:  Stephan Windecker; Andreas Wahl; Krassen Nedeltchev; Marcel Arnold; Markus Schwerzmann; Christian Seiler; Heinrich P Mattle; Bernhard Meier
Journal:  J Am Coll Cardiol       Date:  2004-08-18       Impact factor: 24.094

Review 10.  Patent foramen ovale in cryptogenic stroke: current understanding and management options.

Authors:  Lambert A Wu; Joseph F Malouf; Joseph A Dearani; Donald J Hagler; Guy S Reeder; George W Petty; Bijoy K Khandheria
Journal:  Arch Intern Med       Date:  2004-05-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.